Although miR-338-3p has been shown to suppress cell migration and invasion by targeting SMO [13], and reduced expression of miR-338-3p is a frequent event in a variety of cancers [10–12], the involvement of miR-338-3p in EMT has yet to be investigated. Here, SMO is linked to cancer.